Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **zinc metabolism pathway** refers to a complex network of biological processes that regulate the absorption, distribution, storage, utilization, and excretion of **zinc**, an essential trace element. This is not a single molecular entity but rather encompasses numerous proteins—including two major transporter families (**ZIP/SLC39** for influx and **ZnT/SLC30** for efflux), metallothioneins for intracellular storage/buffering, various enzymes requiring zinc as a cofactor (such as carbonic anhydrase and superoxide dismutase), transcription factors with structural dependence on zinc fingers, and regulatory elements controlling gene expression in response to cellular zinc status. The proper functioning of this network is critical for maintaining cellular homeostasis. Dysregulation at any point in this system can contribute to diverse pathologies including cancer progression,[1][2] metabolic syndrome,[1] neurodegeneration,[4] diabetes mellitus,[6] cardiovascular disease,[6] immune dysfunction,[1], among others. While many studies investigate therapeutic targeting of specific components within this system—such as using small molecules against certain ZIP/ZnT transporters—the "zinc metabolism pathway" itself is too broad to be considered a direct drug target.[2][3] Therefore: **Zinc metabolism pathway** is *not* considered a canonical therapeutic target like an enzyme or receptor; it represents an interconnected set of processes involving many targets. For structured data purposes it should be flagged as incorrect if used where only discrete molecular targets are appropriate. --- Supporting details: > “Zinc is involved in conformation and function of nuclear transcription factors... acts as component of superoxide dismutase... plays role in apoptosis & immune response... Dysregulation leads to disturbances in metabolic functions & human diseases...” [1] > “Zinc transportation is under control by two major transporter families: SLC30(ZnT) excretion & SLC39(ZIP) intake... Storage mediated by metallothioneins...” [2] > “Both ZnT & ZIP transporters are indispensable for tightly controlled integrated processes... malfunctioning results in onset/progression variety diseases.” [3] > “It interacts with 'a wide range' organic ligands ... roles RNA/DNA metab., signal transduction/gene expression ... regulates brain excitability/synaptic plasticity.” [4] > “Zn metabolism relies on two proteins ZIP/ZNT ... Abnormal Zn metab. can lead development/progression BC ... explored ability ZMRGs predict prognosis.” [5] > “Dysfunctional zinc signaling associated with chronic disease states including cancer/cardiovascular/Alzheimer’s/diabetes ... achieved through coordinated actions zip/znt/metallothionein.” [6]
Mechanisms are specific to individual proteins within the pathway—e.g., inhibition or activation of ZIP/ZnT transporters—but not for the entire pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc metabolism pathway.